This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2020 Oct 6;173(7):585-587.

doi: 10.7326/L20-0549. Epub 2020 Aug 4.

Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report

Eugene Brailovski¹, Richard B Kim², David Juurlink¹

Affiliations

PMID: 32744865
DOI: 10.7326/L20-0549

Case Reports

Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report

Eugene Brailovski et al. Ann Intern Med. 2020.

. 2020 Oct 6;173(7):585-587.

doi: 10.7326/L20-0549. Epub 2020 Aug 4.

Authors

Eugene Brailovski¹, Richard B Kim², David Juurlink¹

Affiliations

¹ University of Toronto, Toronto, Ontario, Canada (E.B., D.J.).
² University of Western Ontario, London, Ontario, Canada (R.B.K.).

PMID: 32744865
DOI: 10.7326/L20-0549

No abstract available

PubMed Disclaimer

Comment in

Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Brailovski E, Kim RB, Juurlink D. Brailovski E, et al. Ann Intern Med. 2021 Mar;174(3):432. doi: 10.7326/L20-1456. Ann Intern Med. 2021. PMID: 33721527 No abstract available.
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Mamidi RNVS, Devineni D, Sun D, Yavin Y, Rosenthal N. Mamidi RNVS, et al. Ann Intern Med. 2021 Mar;174(3):431-432. doi: 10.7326/L20-1455. Ann Intern Med. 2021. PMID: 33721528 No abstract available.
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Alamer A, Te C, Fazel MT. Alamer A, et al. Ann Intern Med. 2021 Mar;174(3):431. doi: 10.7326/L20-1454. Ann Intern Med. 2021. PMID: 33721529 No abstract available.

Similar articles

Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Alamer A, Te C, Fazel MT. Alamer A, et al. Ann Intern Med. 2021 Mar;174(3):431. doi: 10.7326/L20-1454. Ann Intern Med. 2021. PMID: 33721529 No abstract available.
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Mamidi RNVS, Devineni D, Sun D, Yavin Y, Rosenthal N. Mamidi RNVS, et al. Ann Intern Med. 2021 Mar;174(3):431-432. doi: 10.7326/L20-1455. Ann Intern Med. 2021. PMID: 33721528 No abstract available.
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment.
Brailovski E, Kim RB, Juurlink D. Brailovski E, et al. Ann Intern Med. 2021 Mar;174(3):432. doi: 10.7326/L20-1456. Ann Intern Med. 2021. PMID: 33721527 No abstract available.
Infection-Induced Rhabdomyolysis in an Elderly Patient on Stable Rosuvastatin Therapy: A Case Report and Review of the Literature.
Guo D, Meng Z, He F, Liu G, Huang X. Guo D, et al. Am J Ther. 2022 Nov-Dec 01;29(6):e657-e661. doi: 10.1097/MJT.0000000000001325. Epub 2021 Jan 5. Am J Ther. 2022. PMID: 33443867 Review. No abstract available.
Statin-Associated Diabetes Mellitus: Review and Clinical Guide.
Backes JM, Kostoff MD, Gibson CA, Ruisinger JF. Backes JM, et al. South Med J. 2016 Mar;109(3):167-73. doi: 10.14423/SMJ.0000000000000423. South Med J. 2016. PMID: 26954655 Review.

See all similar articles

Cited by

Rhabdomyolysis and Sodium-Glucose-Linked Transport Inhibitors in Patients Taking Statins.
Harel Z, Jeyakumar N, Smith G, Ray JG, Clemens KK, Juurlink DN. Harel Z, et al. JAMA Netw Open. 2024 Nov 4;7(11):e2446641. doi: 10.1001/jamanetworkopen.2024.46641. JAMA Netw Open. 2024. PMID: 39541123 Free PMC article.
Impact of metformin on statin-associated myopathy risks in dyslipidemia patients.
Bak K, Moon S, Ko M, Choi YJ, Shin S. Bak K, et al. Pharmacol Res Perspect. 2023 Aug;11(4):e01114. doi: 10.1002/prp2.1114. Pharmacol Res Perspect. 2023. PMID: 37417539 Free PMC article.
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary.
Mascolo A, Di Napoli R, Balzano N, Cappetta D, Urbanek K, De Angelis A, Scisciola L, Di Meo I, Sullo MG, Rafaniello C, Sportiello L. Mascolo A, et al. Front Cardiovasc Med. 2022 Sep 21;9:1010693. doi: 10.3389/fcvm.2022.1010693. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211584 Free PMC article. Review.
Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers.
White AMB, Mishcon HR, Redwanski JL, Hills RD Jr. White AMB, et al. J Clin Med. 2020 Nov 21;9(11):3748. doi: 10.3390/jcm9113748. J Clin Med. 2020. PMID: 33233352 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information